Antiviral activity of substituted homoisoflavonoids on enteroviruses

Antiviral Research

Volumn 72, Issue 3, 2006, Pages 252-255

  Tait, Sabrina ^a   Salvati, Anna Laura ^a   Desideri, Nicoletta ^b   Fiore, Lucia ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antivirals; Enteroviruses; Homoisoflavonoids

Indexed keywords

3 (4' CHLOROBENZYL) 4 CHROMONE; 3 (4' HYDROXYBENZYL)CHROMAN 4 ONE; 3 (4' HYDROXYBENZYLIDEN)CHROMAN 4 ONE; 3 (4' METHOXYBENZYL) 4 CHROMONE; DISOXARIL; HOMOISOFLAVONE DERIVATIVE; ISOFLAVONOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; COXSACKIE VIRUS B; COXSACKIE VIRUS B3; COXSACKIE VIRUS B4; DRUG CYTOTOXICITY; ENTEROVIRUS; IC 50; NONHUMAN; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; ENTEROVIRUS; ISOFLAVONES; MOLECULAR STRUCTURE; VIRUS REPLICATION;

CERCOPITHECUS AETHIOPS; COXSACKIEVIRUS; ENTEROVIRUS; HUMAN ECHOVIRUS 30; POLIOVIRUS;

EID: 33750690473     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.07.003     Document Type: Article

References (30)

1. Burali C., Desideri N., Stein M.L., Conti C., and Orsi N. Synthesis and anti-rhinovirus activity of halogen-substituted isoflavenes and isoflavanes. Eur. J. Med. Chem. 22 (1987) 119-123
2. Castrillo J.L., Vanden Berghe D., and Carrasco L. 3-Methylquercetin is a potent and selective inhibitor of poliovirus RNA synthesis. Virology 152 (1986) 219-227
3. Conti C., Genovese D., Santoro R., Stein M.L., Orsi N., and Fiore L. Activities and mechanisms of action of halogen-substituted flavanoids against poliovirus type 2 infection in vitro. Antimicrob. Agents Chemother. 34 (1990) 460-466
4. Conti C., Desideri N., Orsi N., Sestili I., and Stein M.L. Synthesis and anti-rhinovirus activity of cyano and amidino substituted flavanoids. Eur. J. Med. Chem. 25 (1990) 725-730
5. De Meyer N., Haemers A., Mishra L., Pandey H.K., Pieters L.A., Vanden Berghe D.A., and Vlietinck A.J. 4′-Hydroxy-3-methoxyflavones with potent antipicornavirus activity. J. Med. Chem. 34 (1991) 736-746
6. Desideri N., Sestili I., Stein M.L., Conti C., Tomao P., and Orsi N. Synthesis and anti-rhinovirus 1B activity of oxazolinylflavans. Antiviral Chem. Chemother. 1 (1990) 307-312
7. Desideri N., Conti C., Sestili I., Tomao P., Stein M.L., and Orsi N. Synthesis and evaluation of anti-rhinovirus 1B activity of oxazolinyl-isoflavans and -3(2H)-isoflavenes. Antiviral Chem. Chemother. 3 (1992) 195-202
8. Desideri N., Conti C., Sestili I., Tomao P., Stein M.L., and Orsi N. In vitro evaluation of the anti-picornavirus activities of new synthetic flavonoids. Antiviral Chem. Chemother. 6 (1995) 298-306
9. Desideri N., Olivieri S., Stein M.L., Sgro R., Orsi N., and Conti C. Synthesis and anti-picornavirus activity of homo-isoflavonoids. Antiviral Chem. Chemother. 8 (1997) 545-555
10. Di Lonardo A., Buttinelli G., Amato C., Novello F., Ridolfi B., and Fiore L. Rapid methods for identification of poliovirus isolates and determination of polio neutralizing antibody titers in human sera. J. Virol. Meth. 101 (2002) 189-196
11. Genovese D., Conti C., Tomao P., Desideri N., Stein M.L., Catone S., and Fiore L. Effect of chloro-, cyano-, and amidino-substituted flavanoids on enterovirus infection in vitro. Antiviral Res. 27 (1995) 123-136
12. González M.E., Martinez-Abarca F., and Carrasco L. Flavonoids: potent inhibitors of poliovirus RNA synthesis. Antiviral Chem. Chemother. 1 (1990) 203-209
13. Horn D., Fitzpatrick W.C., Gompper P.T., Ochs V., Bolton-Hansen M., Zarling J., Malik N., Todaro G.J., and Linsley P.S. Regulation of cell growth by recombinant oncostatin M. Growth Factors 2 (1990) 157-165
14. Huber S., and Ramsingh A.I. Coxsackievirus-induced pancreatitis. Viral Immunol. 17 (2004) 358-369
15. MacLennan C., Dunn G., Huissoon A.P., Kumararatne D.S., Martin J., O'Leary P., Thompson R.A., Osman H., Wood P., Minor P., Wood D.J., and Pillay D. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 363 (2004) 1509-1513
16. Maier R., Krebs P., and Ludewig B. Immunopathological basis of virus-induced myocarditis. Clin. Dev. Immunol. 11 (2004) 1-5
17. Otto M.J., Fox M.P., Fancher M.J., Kuhrt M.F., Diana G.D., and McKinlay M.A. In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug. Antimicrob. Agents Chemother. 27 (1985) 883-886
18. Pallansch M.A., and Roos R.P. Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In: Fields B.N., Knipe D., and Howley P. (Eds). Virology. 4th ed. (2001), Lippincott Williams & Wilkins, Philadlphia, PA 723-775
19. Pevear D.C., Hayden F.G., Demenczuk T.M., Barone L.R., McKinlay M.A., and Collett M.S. Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses. Antimicrob. Agents Chemother. 49 (2005) 4492-4499
20. Quaglia M.G., Desideri N., Bossu E., Sestili I., Tomao P., Conti C., and Orsi N. Chiral discrimination and antipicornavirus activity of 6-oxazolinylisoflavan. Chirality 5 (1993) 356-358
21. Quaglia M.G., Desideri N., Bossu E., Sgro R., and Conti C. Enatioseparation and anti-rhinovirus activity of 3-benzylchroman-4-ones. Chirality 11 (1999) 495-500
22. Rawlinson W.D. Antiviral agents for influenza, hepatitis C and herpesvirus, enterovirus and rhinovirus infections. Med. J. Aust. 175 (2001) 112-116
23. Robin V., Irurzun A., Amoros M., Boustie J., and Carrasco L. Antipolio flavanoids from Psiada dentata. Antiviral Chem. Chemother. 12 (2001) 283-291
24. Roivainen M., Rasilainen S., Ylipaasto P., Nissinen R., Ustinov J., Bouwens L., Eizirik D.L., Hovi T., and Otonkoski T. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J. Clin. Endocrinol. Metab. 85 (2000) 432-440
25. Salvati A.L., De Dominicis A., Tait S., Canitano A., Lahm A., and Fiore L. Mechanism of action at the molecular level of the antiviral drug 3(2H)-isoflavene against type 2 poliovirus. Antimicrob. Agents Chemother. 48 (2004) 2233-2243
26. Savolainen C., Hovi T., and Mulders M.N. Molecular epidemiology of echovirus 30 in Europe: succession of dominant sublineages within a single major genotype. Arch. Virol. 146 (2001) 521-537
27. Shih S., Chen S., Hakimelahi G.H., Liu H., Tseng C., and Shia K. Selective human enterovirus and rhinovirus inhibitors: an overview of capsid-binding and protease-inhibiting molecules. Med. Res. Rev. 24 (2004) 449-474
28. Sugarman B.J., Lewis G.D., Eessalu T.E., Aggarwal B.B., and Shepard H.M. Effects of growth factors on the antiproliferative activity of tumor necrosis factors. Cancer Res. 47 (1987) 780-786
29. Tisdale M., and Selway J.W. Effect of dichloroflavan (BW683C) on the stability and uncoating of rhinovirus type 1B. J. Antimicrob. Chemother. 14 Suppl. A (1984) 97-105
30. Van Hoof L., Vanden Berghe D.A., Hatfield G.M., and Vlietinck A.J. Plant antiviral agents; V 3-Methoxyflavones as potent inhibitors of viral-induced block of cell synthesis. Planta Med. 50 (1984) 513-517